NovelMed Therapeutics, Inc
- Biotech or pharma, therapeutic R&D
NovelMed is a clinical-stage biopharmaceutical company developing immunotherapies targeting complement-mediated rare diseases across hematology, nephrology, dermatology, and ophthalmology. Two antibody therapies have successfully completed Phase I clinical trials without any safety concerns. Additionally, one antibody therapy is currently in Phase II trials for a hematological disorder. We have also developed a diagnostic platform that enhances our ability to identify and treat complement-mediated disorders.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}